Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jul 27, 2026; 18(7): 120222
Published online Jul 27, 2026. doi: 10.4240/wjgs.v18.i7.120222
Published online Jul 27, 2026. doi: 10.4240/wjgs.v18.i7.120222
Table 1 Baseline demographic and clinical characteristics of patients before and after propensity score matching, n (%)/mean ± SD
| Characteristic | Pre-matched cohort | Post-matched cohort (n = 125 pairs) | ||||||||
| Watson-FTS | Routine care | Test statistic | P value | SMD | Watson-FTS | Routine care | Test statistic | P value | SMD | |
| Demographics | ||||||||||
| Age, years | 62.1 ± 10.8 | 64.5 ± 11.4 | 1.91 | 0.057 | 0.22 | 63.2 ± 10.5 | 63.5 ± 10.9 | 0.22 | 0.825 | 0.03 |
| Male gender | 96 (58.2) | 85 (57.8) | 0.01 | 0.948 | 0.01 | 72 (57.6) | 71 (56.8) | 0.02 | 0.898 | 0.02 |
| BMI, kg/m2 | 23.6 ± 3.4 | 23.1 ± 3.7 | 1.24 | 0.216 | 0.14 | 23.4 ± 3.2 | 23.3 ± 3.5 | 0.24 | 0.814 | 0.03 |
| Education (> high school) | 91 (55.2) | 59 (40.1) | 6.99 | 0.008 | 0.31 | 58 (46.4) | 60 (48.0) | 0.06 | 0.799 | 0.03 |
| Clinical status | ||||||||||
| ASA class III | 45 (27.3) | 38 (25.9) | 0.08 | 0.776 | 0.03 | 34 (27.2) | 33 (26.4) | 0.02 | 0.887 | 0.02 |
| NRS 2002 score | 2.6 ± 0.9 | 2.5 ± 1.1 | 0.88 | 0.38 | 0.1 | 2.5 ± 0.8 | 2.5 ± 0.9 | 0 | 1 | 0 |
| CCI score | 2.4 ± 1.5 | 2.6 ± 1.7 | 1.1 | 0.272 | 0.12 | 2.5 ± 1.4 | 2.5 ± 1.5 | 0 | 1 | 0 |
| Smoking (current/former) | 64 (38.8) | 61 (41.5) | 0.24 | 0.624 | 0.06 | 49 (39.2) | 51 (40.8) | 0.07 | 0.796 | 0.03 |
| Neoadjuvant therapy | 35 (21.2) | 28 (19.0) | 0.24 | 0.627 | 0.05 | 25 (20.0) | 26 (20.8) | 0.02 | 0.879 | 0.02 |
| Psychological status | ||||||||||
| HADS-anxiety | 9.6 ± 3.1 | 7.9 ± 3.4 | 4.61 | < 0.001 | 0.52 | 8.8 ± 2.9 | 8.9 ± 3.2 | 0.26 | 0.795 | 0.03 |
| HADS-depression | 8.9 ± 3.3 | 7.4 ± 3.2 | 4.07 | < 0.001 | 0.46 | 8.2 ± 3.0 | 8.3 ± 2.8 | 0.27 | 0.785 | 0.03 |
| Surgical/oncological | ||||||||||
| Laparoscopic approach | 140 (84.8) | 101 (68.7) | 11.52 | 0.001 | 0.4 | 95 (76.0) | 94 (75.2) | 0.02 | 0.885 | 0.02 |
| AJCC TNM stage III | 88 (53.3) | 76 (51.7) | 0.08 | 0.775 | 0.03 | 66 (52.8) | 65 (52.0) | 0.02 | 0.898 | 0.02 |
| Tumor location (rectum) | 102 (61.8) | 94 (63.9) | 0.15 | 0.697 | 0.04 | 78 (62.4) | 79 (63.2) | 0.02 | 0.894 | 0.02 |
| Permanent stoma | 65 (39.4) | 62 (42.2) | 0.25 | 0.617 | 0.06 | 50 (40.0) | 49 (39.2) | 0.02 | 0.892 | 0.02 |
| Preop albumin, g/L | 36.4 ± 4.5 | 36.9 ± 4.8 | 0.95 | 0.343 | 0.11 | 36.6 ± 4.2 | 36.7 ± 4.4 | 0.18 | 0.854 | 0.02 |
| Preop prealbumin, mg/L | 224 ± 51 | 219 ± 55 | 0.83 | 0.407 | 0.09 | 221 ± 48 | 223 ± 50 | 0.32 | 0.748 | 0.04 |
- Citation: Jiang D, Shang FJ, Yu W. Association of Watson-based humanistic fast track surgery with stoma colorectal cancer recovery: A propensity matched study. World J Gastrointest Surg 2026; 18(7): 120222
- URL: https://www.wjgnet.com/1948-9366/full/v18/i7/120222.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i7.120222